Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment With Lanreotide Autogel (Somatostatin Analogue) in Patients With Congenital Hyperinsulinism of Infancy Already Treated With Somatostatin Analog by Pump

NCT01070758 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT01070758
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01070758 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment With Lanreotide Autogel (Somatostatin Analogue) in Patients With Congenital Hyperinsulinism of Infancy Already Treated With Somatostatin Analog by Pump
Lead sponsor
Sheba Medical Center
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2010
Completion date
February 28, 2015
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital hyperinsulinism